Current Research Studies
Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) s.c. once weekly versus placebo in children and adolescents with type 2 diabetes
REIMAGINE YOUNG
What is the goal of the study?
A research study to see how much CagriSema lowers blood sugar and body weight compared to placebo in children and adolescents with type 2 diabetes
Who can participate in the study?
Please contact the study team listed below to learn more.